These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 28502611)

  • 1. Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.
    Singh B; Modica-Napolitano JS; Singh KK
    Semin Cancer Biol; 2017 Dec; 47():1-17. PubMed ID: 28502611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial determinants of cancer health disparities.
    Choudhury AR; Singh KK
    Semin Cancer Biol; 2017 Dec; 47():125-146. PubMed ID: 28487205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numtogenesis as a mechanism for development of cancer.
    Singh KK; Choudhury AR; Tiwari HK
    Semin Cancer Biol; 2017 Dec; 47():101-109. PubMed ID: 28511886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria Can Cross Cell Boundaries: An Overview of the Biological Relevance, Pathophysiological Implications and Therapeutic Perspectives of Intercellular Mitochondrial Transfer.
    Valenti D; Vacca RA; Moro L; Atlante A
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Transfer in Cancer: A Comprehensive Review.
    Zampieri LX; Silva-Almeida C; Rondeau JD; Sonveaux P
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33806730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial-induced Epigenetic Modifications: From Biology to Clinical Translation.
    Sharma J; Kumari R; Bhargava A; Tiwari R; Mishra PK
    Curr Pharm Des; 2021; 27(2):159-176. PubMed ID: 32851956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The known unknowns of mitochondrial carcinogenesis: de novo NUMTs and intercellular mitochondrial transfer.
    Harutyunyan T
    Mutagenesis; 2024 Feb; 39(1):1-12. PubMed ID: 37804235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria transfer and transplantation in human health and diseases.
    Wang ZH; Chen L; Li W; Chen L; Wang YP
    Mitochondrion; 2022 Jul; 65():80-87. PubMed ID: 35623561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprogramming Oxidative Phosphorylation in Cancer: A Role for RNA-Binding Proteins.
    Esparza-Moltó PB; Cuezva JM
    Antioxid Redox Signal; 2020 Nov; 33(13):927-945. PubMed ID: 31910046
    [No Abstract]   [Full Text] [Related]  

  • 12. Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression.
    Carden T; Singh B; Mooga V; Bajpai P; Singh KK
    J Biol Chem; 2017 Dec; 292(50):20694-20706. PubMed ID: 29066618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria and Cancer.
    Zong WX; Rabinowitz JD; White E
    Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism.
    Rogalinska M
    Mini Rev Med Chem; 2016; 16(7):524-30. PubMed ID: 26471969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial-epigenetic crosstalk in environmental toxicology.
    Weinhouse C
    Toxicology; 2017 Nov; 391():5-17. PubMed ID: 28855114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Mitochondrial Components and Effects on Cardiovascular Disease.
    Xu Y; Yu Y; Yang B; Hui J; Zhang C; Fang H; Bian X; Tao M; Lu Y; Shang Z
    DNA Cell Biol; 2021 Sep; 40(9):1131-1143. PubMed ID: 34370602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways.
    Kaipparettu BA; Ma Y; Park JH; Lee TL; Zhang Y; Yotnda P; Creighton CJ; Chan WY; Wong LJ
    PLoS One; 2013; 8(5):e61747. PubMed ID: 23671572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics.
    Guha M; Avadhani NG
    Mitochondrion; 2013 Nov; 13(6):577-91. PubMed ID: 24004957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
    Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.